Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to catch lung cancer earlier statewide

NCT ID NCT07639255

Knowledge-focused Sponsor: Timothy Mullett Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study tests a program called QUILS to help hospitals and clinics run better lung cancer screening programs. Researchers will work with 330 healthcare staff across Kentucky to identify weak spots and improve screening quality. The goal is to catch more lung cancers early, when they are easier to treat.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
QUILS System (educational outreach and quality improvement program)
What this could lead to
If successful, this could provide a proven method to make lung cancer screening more effective and equitable across entire states.
What could go wrong
This is an early-stage implementation study, not a direct treatment trial. Results may not apply to other regions or guarantee better health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 330 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program. * Willing to participate in the QUILS Index Assessment Survey process * Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews Exclusion Criteria: * Unwilling to participate in the QUILS Index Assessment Survey process * Unwilling to participate in the QUILS Audit Feedback presentations * Unwilling to participate in formative evaluation interviews

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer screening

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    17 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clark Regional Medical Center

    RECRUITING

    Winchester, Kentucky, 40391, United States

  • Georgetown Cancer Treatment Cancer

    RECRUITING

    Georgetown, Kentucky, 40324, United States

  • Hazard Appalachian Regional Healthcare Medical Center

    RECRUITING

    Hazard, Kentucky, 41701, United States

  • King's Daughter's Medical Center

    RECRUITING

    Ashland, Kentucky, 41101, United States

  • Lake Cumberland Regional Hospital

    RECRUITING

    Somerset, Kentucky, 42501, United States

  • Lexington VA Health Care System

    RECRUITING

    Lexington, Kentucky, 40502, United States

  • Meadowview Regional Medical Center

    RECRUITING

    Maysville, Kentucky, 41056, United States

  • Mercy Health - Paducah Cancer Center

    RECRUITING

    Paducah, Kentucky, 42003, United States

  • Owensboro Health Mitchell Memorial Cancer Center

    RECRUITING

    Owensboro, Kentucky, 42303, United States

  • Rockcastle Regional Hospital

    RECRUITING

    Mount Vernon, Kentucky, 40456, United States

  • Saint Claire Regional Medical Center

    RECRUITING

    Morehead, Kentucky, 40351, United States

  • St. Elizabeth Healthcare

    RECRUITING

    Edgewood, Kentucky, 41017, United States

  • St. Joseph Health (Catholic Health Initiatives)

    RECRUITING

    Lexington, Kentucky, 40504, United States

  • TJ Samson Community Hospital

    RECRUITING

    Glasgow, Kentucky, 42141, United States

  • Taylor Regional Hospital

    RECRUITING

    Campbellsville, Kentucky, 42718, United States

  • The James Graham Brown Cancer Center at University of Louisville

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • University of Kentucky Markey Cancer Center

    RECRUITING

    Lexington, Kentucky, 40536, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.